India's Leading Life Sciences Private Equity Firm
InvAscent has a successful track record of partnering with entrepreneurs in the Indian pharma, healthcare delivery, medtech, and animal health industries, enabling creation of market leaders. Our focus is on small and mid-sized businesses in the Indian pharma, healthcare, animal health, and medtech industries that are in need of growth capital. InvAscent invests through the India Life Sciences Funds, with investments spanning pharmaceuticals, healthcare delivery, medical devices, animal health, nutraceuticals and healthtech.
Hariharnath Buggana
Chairman & Managing Director, InvAscent
Hariharnath (Hari) Buggana is the Chairman and Managing Director of InvAscent and the designated investment professional for India Life Sciences Fund IV per IFC's project documentation. He holds an MBA from J.L. Kellogg Graduate School of Management, Northwestern University, an MS in Chemical Engineering from Illinois Institute of Technology, and a BE in Chemical Engineering from University of Poona.
Nithya Govind
Managing Director
Nithya Govind is Managing Director at InvAscent and the SEBI-designated contact person for India Life Sciences Fund IV Domestic. She leads investment execution in the pharma and API space. She quoted on the Fleming Laboratories investment: 'with great chemistry skills and excellent operational capabilities, Fleming has established itself as one of the fastest growing API companies.' She also led the Geri Care Health Services eldercare investment.
T.P. Devarajan
Partner / Investment Team, InvAscent
T.P. Devarajan is a Partner at InvAscent contributing to investment execution and portfolio management for the ILSF fund family.
Anil Jagirdar
Director, InvAscent
Anil Jagirdar is a Director at InvAscent. He led the ABI Health Technologies investment (ILSF IV), stating: 'Indian Health-Tech is always seen as a challenging space but we see this changing rapidly with increasing adoption of tech.' He holds an MBA from IIM Shillong and a BTech in Biotechnology from Osmania University.
Paritosh Nayak
Investment Team, InvAscent
Paritosh Nayak has 13+ years in private equity and healthcare. Prior to InvAscent, he worked at Dr. Reddy's Laboratories (6 years), Jubilant Life Sciences (2 years), and Mylan India. He holds a PGP from ISB Hyderabad and Master & Bachelor of Pharmacy from Jadavpur University.
Investments in securities markets are subject to market risks. Read all the related documents carefully before investing. Past performance is not indicative of future returns.
Henal Vora
Investment Team, InvAscent
Henal Vora previously served as VP at Tata Capital Healthcare Fund (2 investments, portfolio management), led M&A for Piramal Pharma's critical care business, and spent 5 years at KPMG investment banking. He holds an MBA from IIM Indore and BTech (CS) from IIT Kharagpur.
Ankit Pawar
Investment Team, InvAscent
Ankit Pawar has 11+ years in PE, investment banking, and healthcare. Previously an Investment Banking Associate at Torreya Partners (global healthcare IB, 6 years) and Corporate Strategy Manager at Nectar Lifesciences. Holds MBA from University Business School, Panjab University, and BTech in Biotechnology from Thapar University.
Ashwini Mogilisetty
Investment Team, InvAscent
Ashwini Mogilisetty has 6+ years in PE and investment banking. Previously an Investment Analyst at Eversource Capital (2 years) and in investment banking prior to that.
Hemant Ajmera
Complaint Redressal Appellate Officer
Hemant Ajmera has 12+ years in financial services and corporate finance. Previously VP (Finance) at Equirus Securities (fund administration, accounting, investor reporting), and 6 years at GVFL (VC fund) and SBICap Trustee in financial controllership. Holds BCom from Mohanlal Sukhadiya University, CA and CS designations.
Dr. Jeevak Gupta
Managing Director
Dr.
Bhavesh Sonesara
Complaint Redressal Officer
Henal Agrawal
May Philips
Neha Pereira
Dr. Sankalp Anand
Dr.
Shivam Rajoriya
Shweta Agrawal
Venkata Sainath Dadi
© 2026 Wisefolio. Legal and disclaimers